Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2008
12/09/2008US7462704 use of RL9/RL10 protein and the polynucleotides encoding RL9/RL10 protein, e.g., in diagnosing and treating tumor, as well as the pharmaceutical composition containing RL9/RL10 protein or the antibody against it
12/09/2008US7462701 protein purification of high-value heterologous proteins produced in plants, plant derived tissue or plant cells; non-denaturing
12/09/2008US7462698 Anti-CD26 antibodies and methods of use thereof
12/09/2008US7462697 Methods for antibody engineering
12/09/2008US7462696 Human antibodies that have MN binding and cell adhesion-neutralizing activity
12/09/2008US7462693 Variants of the Gamma Chain of AMPX, DNA sequences encoding the same, and uses thereof
12/09/2008US7462692 vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides
12/09/2008US7462690 form a carboxyl-terminal amide of a desired peptide comprising contacting a substrate polypeptide and a palladium complex, where the palladium complex is a palladium(II) or palladium(IV) complex
12/09/2008US7462481 Glyphosate N-acetyltransferase (GAT) genes
12/09/2008US7462478 Polynucleotide encoding 2-hydroxyisoflavanone dehydratase and application of the same
12/09/2008US7462477 Protein-deamidating enzyme, microorganism producing the same, gene encoding the same, production process therefor, and use thereof
12/09/2008US7462476 Methods for large scale production of recombinant DNA-derived tPA or K2S molecules
12/09/2008US7462466 Porcine CD59 nucleic acids and cells containing the same
12/09/2008US7462465 Nucleic acid encoding KCNB potassium channel
12/04/2008WO2008148104A1 Novel vlps derived from cells that do not express a viral matrix or core protein
12/04/2008WO2008147816A2 Compositions and methods for the display of proteins on the surface of bacteria and their derived vesicles and uses thereof
12/04/2008WO2008146797A1 NOVEL GPIIIa GENE
12/04/2008WO2008146019A2 Method for baculovirus generation from insect cells in high-troughput plates
12/04/2008WO2008145013A1 Fusion protein comprising targeting peptide of cd13 and lidamycin
12/04/2008WO2008144900A1 A method of enhancing recombinant protein production
12/04/2008WO2008144891A1 Humanized and chimeric anti-trop-2 antibodies that mediate cancer cell cytotoxicity
12/04/2008WO2008144890A1 Chimeric and humanized anti-cd44 antibodies that mediate cancer cell cytotoxicity
12/04/2008WO2008144889A1 Humanized and chimeric anti-cd59 antibodies that mediate cancer cell cytotoxicity
12/04/2008WO2008125685A3 Whey protein hydrolysate
12/04/2008WO2008112232A3 Methods for monitoring gamma secretase inhibition in vivo
12/04/2008WO2008074004A3 Human antibodies that bind cd70 and uses thereof
12/04/2008WO2008057634A3 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
12/04/2008WO2008054792A3 Na+/k+-atpase-specific peptide inhibitors/activators of src and src family kinases
12/04/2008WO2008039361A3 Method for enhancing immune responses in mammals
12/04/2008WO2008036675A3 Compositions and methods of enhancing immune responses
12/04/2008WO2008019183A3 Biopolymer and protein production using type iii secretion systems of gram negative bacteria
12/04/2008WO2007130403A3 REGULATION OF ApoB BY Hspl 10 PROTEINS AND RELATED COMPOSITIONS AND METHODS
12/04/2008WO2007120166A3 Miniaturized in vitro protein expression array
12/04/2008WO2007106728A3 Soybean seed and oil compositions and methods of making same
12/04/2008WO2007095527A3 Metal-enhanced chemiluminescence (mec)
12/04/2008WO2007089862A3 Alpha-synuclein kinase
12/04/2008US20080301826 Novel beta-actin and rps21 promoters and uses thereof
12/04/2008US20080301824 Parkin interacting polypeptides and methods of use
12/04/2008US20080300207 Protein production
12/04/2008US20080300188 hybrid Fc; useful as a carrier of biologically active molecules
12/04/2008US20080300187 Mutated hoxb4 proteins with improved stability, and methods of use thereof
12/04/2008US20080300167 Patched genes and uses related thereto
12/04/2008US20080300163 Modified Human Four Helical Bundle Polypeptides And Their Uses
12/04/2008US20080299678 Methods for characterizing glycosylation sites
12/04/2008US20080299640 Acid alpha-glucosidase and fragments thereof
12/04/2008US20080299619 Given amino acid sequence; for use in animal feeds and detergents, starch conversion, ethanol production
12/04/2008US20080299618 Single domain ligands, receptors comprising said ligands, methods for their production and use of said ligands and receptors
12/04/2008US20080299617 Methods and host cells for recombinant protein expression
12/04/2008US20080299616 Malate Synthase Regulatory Sequences for Heterologous Gene Expression in Pichia
12/04/2008US20080299615 Beta1,3-N-acetyl-D-galactosamine transferase protein, nucleic acid encoding the same and method of examining canceration using the same
12/04/2008US20080299614 Metabolically Engineered Bacterial Strains Having Non-Functional Endogenous Gluconate Transporters
12/04/2008US20080299613 Compositions for degrading cellulosic material
12/04/2008US20080299612 Fusion proteins with cleavable spacers and uses thereof
12/04/2008US20080299611 Host Cell Protein Knock-Out Cells for Production of Therapeutic Proteins
12/04/2008US20080299610 Human toll homologue
12/04/2008US20080299609 Uracil-DNA glycosylase of psychrobacter sp. HJ147 and use thereof
12/04/2008US20080299608 Method for the in vivo modification of the synthesis activity of a metabolite by means of the modification of a gene the activity of which is not the original activity
12/04/2008US20080299607 Ultrafiltration pretreatment; adjustment of pH; enzyme treatment ; deactivation of enzyme
12/04/2008US20080299606 Using microorganisms as bioreactors for propagation of organic compounds comprising 3 C-atoms and/or 2 C-atoms and 1 N-atom
12/04/2008US20080299596 Substrates and assays for beta-secretase activity
12/04/2008US20080299595 Tailored glycoproteomic methods for the sequencing, mapping and identification of cellular glycoproteins
12/04/2008US20080299581 Screening for expressible transfectants in a eukaryotic system
12/04/2008US20080299563 Human map2 gene promoter
12/04/2008US20080299548 polynucleotide having a homology of 95% or more with the polynucleotide specifically expressed in a mouse embryonic stem (ES) cell; used for the detection of an ES cell, screening for a somatic cell nuclear reprogramming substance, screening for a ES cell maintaining substance
12/04/2008US20080299547 Novel stra6 polypeptides
12/04/2008US20080299544 Hcv Multiple Epitope Fusion Antigens With Modified Proteolytic Cleavage Sites And Uses Thereof
12/04/2008US20080299153 B. anthracis prevention and treatment: mutant b. anthracis lacking luxs activity and furanone inhibition of growth, ai-2 quorum sensing, and toxin production
12/04/2008US20080299137 Fusion Proteins That Bind Effector Lymphocytes And Target Cells
12/04/2008US20080299134 Recombinant Anti-Interleukin-9 Antibodies
12/04/2008US20080299133 Anti-Il-12 Antibody Based Vectors, Host Cells, and Methods of Production and Uses
12/04/2008US20080299128 prevent immune cells from binding to other cells by contacting the immune cells and the other cells with a composition with bone marrow stromal cell antigen 2 (Bst2) antagonist; antiinflamatory agents
12/04/2008US20080299127 Protective staphylococcus aureus vaccine based on cell wall-associated proteins
12/04/2008US20080299124 Novel method for the stabilization of chimeric immunoglobulin or immunoglobulin fragments and, and stabilized anti-egp-2 scfv fragment
12/04/2008US20080299120 Multivalent antibodies and uses therefor
12/04/2008US20080299119 Polypeptides homologous to vegf and bmp1
12/04/2008US20080299115 Antibody Variants with Faster Antigen Association Rates
12/04/2008US20080299096 Modified nucleotide sequence encoding glucagon-like peptide-1 (glp-1), nucleic acid construct comprising same for production of glucagon-like peptide-1 (glp-1), human cells comprising said construct and insulin-producing constructs, and methods of use thereof
12/04/2008US20080299082 Novel recombinant T4 phage particle containing HIV, H. pylori or cancer antigens and uses thereof
12/04/2008US20080299081 Polynucleotides and Polypeptides of the IFNalpha-21 Gene
12/04/2008DE102007024852A1 Strongly enriching the amino acids and/or oligopeptides based on sweet whey powder, which is dissolved in water, comprises converting sugar to lactic acid and proteins to oligopeptides and amino acids using protease or lactic acid bacterium
12/04/2008CA2688232A1 A method of enhancing recombinant protein production
12/04/2008CA2687937A1 Novel gpiiia gene
12/04/2008CA2687586A1 Humanized and chimeric anti-trop-2 antibodies that mediate cancer cell cytotoxicity
12/04/2008CA2687583A1 Chimeric and humanized anti-cd44 antibodies that mediate cancer cell cytotoxicity
12/04/2008CA2687575A1 Humanized and chimeric anti-cd59 antibodies that mediate cancer cell cytotoxicity
12/03/2008EP1997900A2 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
12/03/2008EP1997894A2 Biosynthetic binding protein for cancer marker
12/03/2008EP1997891A1 Generation and selection of recombinant varied binding proteins
12/03/2008EP1997877A1 Cell culture substrate
12/03/2008EP1997829A1 Albumin fusion proteins
12/03/2008EP1997512A2 Methods for treating TWEAK-related conditions
12/03/2008EP1996716A2 Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting
12/03/2008EP1996701A1 Cytotoxicity mediation of cells evidencing surface expression of trop-2
12/03/2008EP1996700A1 Cancerous disease modifying antibody 141205-05
12/03/2008EP1996699A1 Cancerous disease modifying antibodies
12/03/2008EP1996697A2 Preventing norvaline and norleucine misincorporation in recombinant proteins
12/03/2008EP1613737A4 Artificial receptors including reversibly immobilized building blocks and methods
12/03/2008EP1149163B1 Chromatographic method for purification of albumin
12/03/2008EP1043395B1 Novel g protein-coupled receptor proteins
12/03/2008EP0606217B2 Ctl4a receptor, fusion proteins containing it and uses thereof
1 ... 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 ... 1125